Veeva Systems Common Stock Net 2012-2025 | VEEV
- Veeva Systems common stock net for the quarter ending April 30, 2025 was $0.000B, a 0% increase year-over-year.
- Veeva Systems common stock net for 2025 was $0B, a 0% decline from 2024.
- Veeva Systems common stock net for 2024 was $0B, a 0% decline from 2023.
- Veeva Systems common stock net for 2023 was $0B, a 0% decline from 2022.
Veeva Systems Annual Common Stock Net (Millions of US $) |
|
---|---|
2025 | $0 |
2024 | $0 |
2023 | $0 |
2022 | $0 |
2021 | $0 |
2020 | $0 |
2019 | $0 |
2018 | $0 |
2017 | $0 |
2016 | $0 |
2015 | $0 |
2014 | $0 |
2013 | $0 |
2012 | $0 |
2011 | $0 |
Veeva Systems Quarterly Common Stock Net (Millions of US $) |
|
---|---|
2025-04-30 | $0 |
2025-01-31 | $0 |
2024-10-31 | $0 |
2024-07-31 | $0 |
2024-04-30 | $0 |
2024-01-31 | $0 |
2023-10-31 | $0 |
2023-07-31 | $0 |
2023-04-30 | $0 |
2023-01-31 | $0 |
2022-10-31 | $0 |
2022-07-31 | $0 |
2022-04-30 | $0 |
2022-01-31 | $0 |
2021-10-31 | $0 |
2021-07-31 | $0 |
2021-04-30 | $0 |
2021-01-31 | $0 |
2020-10-31 | $0 |
2020-07-31 | $0 |
2020-04-30 | $0 |
2020-01-31 | $0 |
2019-10-31 | $0 |
2019-07-31 | $0 |
2019-04-30 | $0 |
2019-01-31 | $0 |
2018-10-31 | $0 |
2018-07-31 | $0 |
2018-04-30 | $0 |
2018-01-31 | $0 |
2017-10-31 | $0 |
2017-07-31 | $0 |
2017-04-30 | $0 |
2017-01-31 | $0 |
2016-10-31 | $0 |
2016-07-31 | $0 |
2016-04-30 | $0 |
2016-01-31 | $0 |
2015-10-31 | $0 |
2015-07-31 | $0 |
2015-04-30 | $0 |
2015-01-31 | $0 |
2014-10-31 | $0 |
2014-07-31 | $0 |
2014-04-30 | $0 |
2014-01-31 | $0 |
2013-10-31 | $0 |
2013-07-31 | $0 |
2013-04-30 | $0 |
2013-01-31 | |
2012-10-31 | $0 |
2012-01-31 | $0 |
2011-01-31 | $0 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $45.621B | $2.747B |
Veeva Systems Inc. offers cloud-based software applications and data solutions for the life sciences industry. The company's product portfolio includes Veeva CRM (customer relationship management), Veeva Vault (content and information management), Veeva Network (customer master and product data management) and Veeva data services (Veeva OpenData and Veeva KOL data). |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Tempus AI (TEM) | United States | $12.054B | 0.00 |
Doximity (DOCS) | United States | $12.025B | 53.35 |
Hims & Hers Health (HIMS) | United States | $10.818B | 89.50 |
IRhythm Technologies (IRTC) | United States | $5.361B | 0.00 |
Hinge Health (HNGE) | United States | $4.529B | 0.00 |
Inspire Medical Systems (INSP) | United States | $2.584B | 37.98 |
Privia Health (PRVA) | United States | $2.580B | 191.09 |
Phreesia (PHR) | United States | $1.705B | 0.00 |
Enovis (ENOV) | United States | $1.691B | 8.94 |
10x Genomics (TXG) | United States | $1.671B | 0.00 |
Azenta (AZTA) | United States | $1.471B | 64.16 |
Schrodinger (SDGR) | United States | $1.456B | 0.00 |
Omnicell (OMCL) | United States | $1.440B | 27.74 |
Clover Health Investments (CLOV) | United States | $1.333B | 0.00 |
Claritev (CTEV) | United States | $1.157B | 0.00 |
Evolent Health (EVH) | United States | $1.053B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.666B | 0.00 |
Veradigm (MDRX) | United States | $0.509B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.504B | 0.00 |
Standard BioTools (LAB) | United States | $0.498B | 0.00 |
Talkspace (TALK) | United States | $0.432B | 129.00 |
Carlsmed (CARL) | $0.365B | 0.00 | |
Butterfly Network (BFLY) | United States | $0.357B | 0.00 |
TruBridge (TBRG) | United States | $0.300B | 52.66 |
Outset Medical (OM) | United States | $0.235B | 0.00 |
Health Catalyst (HCAT) | United States | $0.227B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.215B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.210B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.199B | 0.00 |
CapsoVision (CV) | United States | $0.189B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.130B | 0.00 |
American Well (AMWL) | United States | $0.112B | 0.00 |
CareCloud (CCLD) | United States | $0.108B | 4.90 |
EUDA Health Holdings (EUDA) | Singapore | $0.095B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.092B | 0.00 |
Insight Molecular Diagnostics (IMDX) | United States | $0.070B | 0.00 |
Pulmonx (LUNG) | United States | $0.063B | 0.00 |
111 (YI) | China | $0.054B | 0.00 |
P3 Health Partners (PIII) | United States | $0.051B | 0.00 |
HeartBeam (BEAT) | United States | $0.041B | 0.00 |
Zhongchao (ZCMD) | China | $0.025B | 0.00 |
Precipio (PRPO) | United States | $0.022B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.019B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
HeartSciences (HSCS) | United States | $0.008B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.007B | 0.00 |
MSP Recovery (MSPR) | United States | $0.005B | 0.00 |
Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
Movano (MOVE) | United States | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
PROFUSA (PFSA) | United States | $0.003B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |